KRRO
Korro Bio, Inc.
10.00$
+3.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | 118.2% | -122.2% | -228.1% | – | – | -2,645.3% | -1,229.1% | |
| – | – | 2.8% | 4.3% | 11.3% | – | – | 157.0% | 59.3% | |
| – | – | – | – | 5.7% | – | – | 196.5% | 119.8% | |
| – | – | 168.0% | -81.8% | 6.4% | – | – | 598.5% | -69.2% | |
| – | – | 3.7% | 18.0% | 31.6% | – | – | 788.3% | 8.1% | |
| – | – | -63.1% | 28.1% | -280.8% | – | – | -5,431.4% | 688.3% | |
| – | – | 490.6% | 153.3% | 824.2% | – | – | 3,053.9% | 10.7% | |
| – | – | 545.7% | 54.6% | 315.3% | – | – | -5,022.9% | -529.1% | |
| – | – | 114.5% | -140.2% | -259.7% | – | – | -3,433.6% | -1,237.2% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.